Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$236.22

6.923.02%

At close: Aug 21, 5:00 PM EST

$236.48

0.260.11%

After Hours: 6:51 PM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 4.8% short float

Options Flow▼ 1.74 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

1.74

More puts — Bearish

868 calls · 1,512 puts

Avg Consensus PT

$421

+77.9%

Highest Price Target

$583

+146.5%

Citigroup

Lowest Price Target

$256

+8.3%

Wells Fargo

Short Interest

4.8%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 19, 2026	BMO Capital	David Lebowitz—	+34.5%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+8.3%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+33.2%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+92.4%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+77.6%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+43.8%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+90.3%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+58.6%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+48.0%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+26.9%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+48.0%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+33.6%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+34.5%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+79.7%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+51.0%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+69.1%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+73.4%	$460 → $410	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+73.4%	$505 → $410	Maintained	Buy
Jul 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+105.1%	$470 → $485	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+69.1%	$370 → $400	Maintained	Equal-Weight
Jun 29, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+98.7%	$510 → $470	Maintained	Buy
Jun 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+115.7%	$510 → $510	Maintained	Buy
May 19, 2026	Citigroup	Eric Joseph—	+60.7%	$380	Initiate	Buy
May 5, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+115.7%	$510 → $510	Maintained	Buy
May 1, 2026	RBC Capital	Luca Issi—	+88.2%	$450 → $445	Maintained	Outperform